Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The Lancet HIV

• Publication date

  2015-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S2352-3018(15)00108-3PMID 26423376PMCID PMC4643831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

  2014cited by this paper
• Early initiation of antiretroviral therapy in HIV-infected adults and adolescents: a systematic review

  2014cited by this paper
• Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

  2014cited by this paper
• Eff ects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection : results from the phase 3 HPTN 052 randomised controlled trial

  2014cited by this paper
• The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy

  2014cited by this paper
• Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

  2014cited by this paper
• Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

  2013cited by this paper
• Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

  2013cited by this paper
• Increased HIV Incidence in Men Who Have Sex with Men Despite High Levels of ART-Induced Viral Suppression: Analysis of an Extensively Documented Epidemic

  2013cited by this paper
• Short-course antiretroviral therapy in primary HIV infection.

  2013cited by this paper
• When to start antiretroviral therapy: the need for an evidence base during early HIV infection

  2013cited by this paper
• Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study

  2013cited by this paper
• Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome

  2013cited by this paper
• The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

  2012cited by this paper
• No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial

  2012cited by this paper
• Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents

  2012cited by this paper
• Antiretroviral neurotoxicity

  2012cited by this paper
• Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

  2012cited by this paper
• Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

  2011cited by this paper
• When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries

  2011cited by this paper
• Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir

  2011cited by this paper
• Comparative Effectiveness of Dynamic Treatment Regimes: An Application of the Parametric G-Formula

  2011cited by this paper
• Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.

  2011cited by this paper
• Prevention of HIV-1 infection with early antiretroviral therapy

  2011cited by this paper
• A Systematic Review of the Psychiatric Side-Effects of Efavirenz

  2011cited by this paper
• Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

  2010cited by this paper
• Effect of early versus deferred antiretroviral therapy for HIV on survival.

  2009cited by this paper
• Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

  2009cited by this paper
• Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.

  2009cited by this paper
• Estimation of the causal effects of time-varying exposures

  2008cited by this paper
• Estimation of the causal effects of time-varying exposures

  2008cited by this paper
• Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

  2008cited by this paper
• Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

  2008cited by this paper
• European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV‐infected adults

  2008cited by this paper
• CD4+ count-guided interruption of antiretroviral treatment.

  2006cited by this paper
• Longitudinal Data Analysis

  2006cited by this paper
• A Structural Approach to Selection Bias

  2004cited by this paper
• Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000

  1998cited by this paper
• Expanded European AIDS case definition

  1993cited by this paper
• Expanded European AIDS case definition.

  1993cited by this paper
• A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect

  1986cited by this paper

• Time-smoothed inverse probability weighted estimation of effects of generalized time-varying treatment strategies on repeated outcomes truncated by death

  2025cites this paper
• Estimating average causal effects with incomplete exposure and confounders

  2025cites this paper
• Applications and reporting of causal inference modelling in infectious disease studies: A systematic review

  2025cites this paper
• Multi-source analyses of average treatment effects with failure time outcomes

  2025cites this paper
• Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder

  2024cites this paper
• Deep Learning Methods for the Noniterative Conditional Expectation G-Formula for Causal Inference from Complex Observational Data

  2024cites this paper
• Enhanced Cohort Methods for HIV Research and Epidemiology (ENCORE): Protocol for a Nationwide Hybrid Cohort for Transgender Women in the United States

  2024cites this paper
• Demographic and clinical factors correlated with clinical outcomes among people with HIV treated by antiretroviral therapy: a retrospective cohort study

  2024cites this paper
• Evaluating Natural Course Performance in Parametric G-formula: Review of Current Practice and Illustration Based on the United Autoworkers-General Motors Cohort.

  2024cites this paper
• Rapid antiretroviral therapy and treatment outcomes among people living with HIV: exploring the mediating roles of medication adherence

  2024cites this paper
• Real-world clinical and economic outcomes from rapid start antiretroviral therapy in HIV: systematic review and meta-analysis

  2024cites this paper
• Survival times of HIV/AIDS in different AIDS Diagnostic and Treatment Guidelines from 2006 to 2020 in Liuzhou, China

  2023cites this paper
• Evaluating model specification when using the parametric g-formula in the presence of censoring.

  2023cites this paper
• Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.

  2023cites this paper
• Estudio transversal sobre la percepción de los factores favorecedores de la actividad investigadora en enfermedades infecciosas

  2023cites this paper
• Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992–2018: A Cohort Study

  2022cites this paper
• Benchmarking Observational Analyses Before Using Them to Address Questions Trials Do Not Answer: An Application to Coronary Thrombus Aspiration

  2022cites this paper
• Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection

  2022cites this paper
• Estimating the causal effect of treatment with direct-acting antivirals on kidney function among individuals with hepatitis C virus infection

  2022cites this paper
• Motivations and Barriers to Routine HIV Testing Among Men Who Have Sex with Men in New York City

  2022cites this paper
• Comparison of a Target Trial Emulation Framework vs Cox Regression to Estimate the Association of Corticosteroids With COVID-19 Mortality

  2022cites this paper
• Timeliness of antiretroviral therapy initiation in the era before universal treatment

  2021cites this paper
• Multiply robust estimators of causal effects for survival outcomes

  2021cites this paper
• Avoiding Time-Related Biases: A Feasibility Study on Antidiabetic Drugs and Pancreatic Cancer Applying the Parametric g-Formula to a Large German Healthcare Database

  2021cites this paper
• Revisiting the g-null Paradox

  2021cites this paper
• A scoping review of studies using observational data to optimise dynamic treatment regimens

  2021cites this paper
• Rapid Start of Antiretroviral Therapy in Youth Diagnosed with HIV Infection.

  2020cites this paper
• Evaluation of Prognostic response in HIV positive patients after Antiretroviral Therapy

  2020cites this paper
• Parametric g‐formula implementations for causal survival analyses

  2020influential citation
• Incorporation of the rapid HIV test in a sexually-transmitted disease clinic in Buenos Aires: Dramatic increase in the frequency of HIV diagnosis.

  2020cites this paper
• Effects of daily treatment with acid suppressants for stress ulcer prophylaxis on risk of ventilator-associated events

  2019cites this paper
• HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study

  2019cites this paper
• A systematic review and cost-effectiveness analyses of the new World Health Organization guidelines for the treatment of HIV-positive adults in India.

  2019cites this paper
• Effect estimates in randomized trials and observational studies: comparing apples with apples.

  2019cites this paper
• Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial

  2019cites this paper
• Validation of HIV‐infected cohort identification using automated clinical data in the Department of Veterans Affairs

  2019cites this paper
• Two decades of surveillance data show late presentation among a diverse group of women diagnosed with HIV in Victoria, Australia

  2019cites this paper
• Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2019cites this paper
• Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.

  2019cites this paper
• Immediate antiviral therapy for HIV-infected persons faces with various obstacles.

  2019cites this paper
• Refining the Association Between Body Mass Index and Atrial Fibrillation: G‐Formula and Restricted Mean Survival Times

  2019cites this paper
• Impure policies: controversy in HIV prevention and the making of evidence

  2019influential citation
• Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy

  2019cites this paper
• Long-term moderately elevated LDL-cholesterol and blood pressure and risk of coronary heart disease

  2018cites this paper
• Serious Non-AIDS Conditions in HIV: Benefit of Early ART

  2018cites this paper
• Cardiac status of perinatally HIV-infected children: assessing combination antiretroviral regimens in observational studies

  2018cites this paper
• Duration of Human Immunodeficiency Virus Infection at Diagnosis among New Human Immunodeficiency Virus Cases in Dehong, Yunnan, China, 2008–2015

  2018cites this paper
• Nationwide Cohort Study of Antiretroviral Therapy Timing: Treatment Dropout and Virological Failure in China, 2011–2015

  2018cites this paper
• Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g‐Formula to Anemia Management Strategies

  2018cites this paper
• From CD4-Based Initiation to Treating All HIV-Infected Adults Immediately: An Evidence-Based Meta-analysis

  2018cites this paper
• Mortalité et activation immunitaire chronique chez les personnes vivant avec le VIH naïves de traitement antirétroviral en Afrique de l’Ouest

  2018cites this paper
• A Review of Time Scale Fundamentals in the g-Formula and Insidious Selection Bias

  2018cites this paper
• The contribution of observational studies in supporting the WHO ‘treat all’ recommendation for HIV/AIDS

  2018cites this paper
• Using Observational Data to Calibrate Simulation Models

  2017cites this paper
• Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study

  2017cites this paper
• Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older

  2017cites this paper
• CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at Centre Medico-Social Cor-Unum, Kigali

  2017cites this paper
• Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance

  2017cites this paper
• Evaluación de la transición a unidades de adultos de los adolescentes con VIH de transmisión vertical de CoRISpe

  2016cites this paper
• Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection.

  2016cites this paper
• [Treating HIV disease: back to the patient?]

  2016cites this paper
• O tratamento da coinfecção HIV-TB

  2016influential citation
• Agent-Based Models for Causal Inference

  2016cites this paper
• Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.

  2016influential citation
• Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

  2015cites this paper
• Caracterização clínica e epidemiológica de pacientes HIV positivos em início de terapia antirretroviral no Piauí

  2015cites this paper
• When is the best time to initiate antiretroviral therapy?

  2015cites this paper